Did you know?

2001: The FDA approves Gleevec®, a drug developed by LLS-funded researcher Brian Druker, M.D., to treat patients with CML and other blood cancers.

The Word:

promo_left_donate

Press Releases

Read recent and archived press releases about important blood cancer and health news and past and current news and events from The Leukemia & Lymphoma Society.

The press releases below start in reverse chronological order, with the most recent at the top. You can also search press releases by date.

/ /

Displaying results  1 - 5:

Most recent

Thu, 6 Jun 2013

The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities

Partnership Seeks to Accelerate Development of Innovative Therapies

Read More

Wed, 5 Jun 2013

LLS Applauds FDA's Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Approval marks first oral therapy for MCL patients, and a new option for patients with unmet medical need

Read More

Wed, 22 May 2013

The Leukemia & Lymphoma Society and Valor Biotherapeutics Partner to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients

Anti-CD20-Interferon Alpha Fusion Protein is a promising therapy for NHL patients resistant to standard therapy

Read More

Thu, 4 Apr 2013

Researchers Funded by The Leukemia & Lymphoma Society Present Innovative Science at AACR Annual Meeting 2013

Advances in targeted therapies, immunotherapies and epigenetics among highlights

Read More

Wed, 3 Apr 2013

Take the Skyhook Challenge and Help Beat Blood Cancer

LLS Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer

Read More

« Previous    1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10    Next »
last updated on Tuesday, February 15, 2011
btn_sharethis

E-Newsletters


Sign Up For Free

Subscribe to one of LLS's Monthly eNewsletters
Your Name

Your Email

Your Zip Code


About E-News»